Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews Inks $10M Financing Agreement With Milost Global

NEW YORK (GenomeWeb) – Canadian diagnostic developer GeneNews said today that it has signed a binding agreement with multinational private equity firm Milost Global for up to $10 million in equity and debt financing.

Under the agreement, Milost will initially purchase up to $3 million in unsecured convertible notes from GeneNews. The notes will be convertible at a price equal to the five-day volume-weighted average price of common shares of GeneNews on the Toronto Stock Exchange on the day of the draw-down notice, plus a 200 percent premium.

The notes will also have a five-year term from date of issue and bear interest at 5 percent annually, with interest payable quarterly in cash.

The initial $3 million draw-down is expected to be completed in the next 20 business days, and forms part of an equity and debt subscription agreement between GeneNews and Milost for up to $10 million in total proceeds.

The agreement also includes an investment from Milost of up to an additional $3 million in unsecured convertible notes to be drawn down at GeneNews' option, and up to $4 million to be drawn down, also at the company's option, in maximum installments of $1 million.

GeneNews said it will use proceeds from the agreement for working capital and corporate growth purposes, including the continued execution of its growth strategy for its Virginia-based clinical reference lab business, Innovative Diagnostic Laboratory.

In March, GeneNews reached a settlement agreement with the liquidating trust for its former partner Health Diagnostics Laboratory, which had formed the IDL venture along with GeneNews and Cobalt Healthcare Consultants.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.